In addition, another study shows that four-and-a-half LIM 2 (FHL2) interacts with FOXO1 to facilitate SIRT1-mediated deacetylation to reduce FOXO1 activity in prostate cancer [188]. This evidence concerns the gene FOXO1 and prostate cancer.